Assessing the Prognosis of Patients with Metastatic or Recurrent Non-small Cell Lung Cancer in the Era of Immunotherapy and Targeted Therapy.
Seweryn GaleckiMarzena KysiakEmilia KozlowskaAgata Malgorzata WilkRafal SuwinskiAndrzej SwierniakPublished in: PCBBE (2023)
Keyphrases
- lung cancer
- prognostic factors
- breast cancer
- early detection
- survival prediction
- cancer cells
- therapy planning
- lung cancer patients
- automated detection
- disease progression
- clinical trials
- clinical decision making
- stem cell
- cancer diagnosis
- patient specific
- acute myeloid
- cancer patients
- pet ct
- lymph nodes
- pulmonary nodules
- microscopy images
- risk factors
- computer aided diagnosis
- gene selection
- logistic regression
- cell segmentation
- decision support system
- clinical data
- quantitative analysis